# Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

> **NCT01792804** · PHASE3 · COMPLETED · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 215 (actual)

## Conditions studied

- Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Trimethoprim-Sulfamethoxazole
- **DRUG:** Clindamycin
- **DRUG:** Linezolid
- **DRUG:** Flucloxacillin
- **DRUG:** Cloxacillin
- **DRUG:** Vancomycin
- **DRUG:** Daptomycin
- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT01792804
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2020-03-26
- **Final completion:** 2020-03-26
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2020-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792804, "Staphylococcus Aureus Bacteremia Antibiotic Treatment Options". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01792804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*